Vladimir Muzykantov, MD, PhD

Founders Professor in Nanoparticle Research, Pharmacology, Penn Founding Co-Director, Center for Targeted Therapeutics and Translational Nanomedicine (CT3N), Penn Expertise: Targeted Drug Delivery, Vascular Biology, LNP Design & Testing (MRG-2)